Overview of Multiplex Immunohistochemistry and Immunofluorescence Techniques in the Lung Cancer Immunotherapy
Lung cancer is the most common malignancy and is a major public health problem worldwide. Programmed cell death receptor 1 (PD-1)/programmed cell death ligand 1 (PD-L1) inhibitors provide a new treatment strategy for non-small cell lung cancer (NSCLC). The existing biomarkers all have advantages and...
Main Authors: | Wenjia SUN, Jianya ZHOU, Jianying ZHOU |
---|---|
Format: | Article |
Language: | zho |
Published: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2021-01-01
|
Series: | Chinese Journal of Lung Cancer |
Subjects: | |
Online Access: | http://dx.doi.org/10.3779/j.issn.1009-3419.2020.102.47 |
Similar Items
-
Comparison of Multiplexed Immunofluorescence Imaging to Chromogenic Immunohistochemistry of Skin Biomarkers in Response to Monkeypox Virus Infection
by: Anup Sood, et al.
Published: (2020-07-01) -
Multiplex Immunofluorescence Tyramide Signal Amplification for Immune Cell Profiling of Paraffin-Embedded Tumor Tissues
by: Sharia Hernandez, et al.
Published: (2021-04-01) -
Chromogenic Multiplex Immunohistochemistry Reveals Modulation of the Immune Microenvironment Associated with Survival in Elderly Patients with Lung Adenocarcinoma
by: Marius Ilié, et al.
Published: (2018-09-01) -
Best Practices for Technical Reproducibility Assessment of Multiplex Immunofluorescence
by: Caddie Laberiano-Fernández, et al.
Published: (2021-08-01) -
A robust multiplex immunofluorescence and digital pathology workflow for the characterisation of the tumour immune microenvironment
by: Amélie Viratham Pulsawatdi, et al.
Published: (2020-10-01)